Vietnamese (HOSE) Healthcare Sector Analysis
UpdatedApr 25, 2024
DataAggregated Company Financials
Companies23
- 7D-1.0%
- 3M4.7%
- 1Y12.2%
- YTD5.3%
Over the last 7 days, the Healthcare industry has dropped 1.7%, driven by Imexpharm declining 7.9%. Meanwhile, Ha Tay Pharmaceutical JSC actually outperformed within the industry, gaining 7.5% in the last week. This takes the industry's 12 month performance to a gain of 12%. Looking forward, earnings are forecast to grow by 8.6% annually.
Sector Valuation and Performance
Has the Vietnamese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 25 Apr 2024 | ₫43.0t | ₫19.3t | ₫2.2t | 15.1x | 19.3x | 2.2x |
| Sat, 23 Mar 2024 | ₫43.8t | ₫19.2t | ₫2.4t | 14.9x | 18.2x | 2.3x |
| Mon, 19 Feb 2024 | ₫41.2t | ₫19.2t | ₫2.4t | 13.9x | 16.9x | 2.1x |
| Wed, 17 Jan 2024 | ₫41.3t | ₫18.9t | ₫2.4t | 15x | 17.5x | 2.2x |
| Fri, 15 Dec 2023 | ₫39.2t | ₫18.9t | ₫2.4t | 13.6x | 16.7x | 2.1x |
| Sun, 12 Nov 2023 | ₫40.0t | ₫18.9t | ₫2.4t | 14.2x | 17x | 2.1x |
| Tue, 10 Oct 2023 | ₫43.1t | ₫17.4t | ₫2.4t | 14.7x | 18.2x | 2.5x |
| Thu, 07 Sep 2023 | ₫44.0t | ₫17.4t | ₫2.4t | 14.7x | 18.6x | 2.5x |
| Sat, 05 Aug 2023 | ₫43.7t | ₫17.4t | ₫2.4t | 14.4x | 18.3x | 2.5x |
| Mon, 03 Jul 2023 | ₫44.1t | ₫17.2t | ₫2.3t | 13.5x | 19.1x | 2.6x |
| Wed, 31 May 2023 | ₫38.9t | ₫17.2t | ₫2.3t | 13.8x | 16.8x | 2.3x |
| Fri, 28 Apr 2023 | ₫37.2t | ₫17.4t | ₫2.4t | 11.5x | 15.8x | 2.1x |
| Sun, 26 Mar 2023 | ₫34.9t | ₫18.8t | ₫2.4t | 11.2x | 14.4x | 1.9x |
| Tue, 21 Feb 2023 | ₫75.3t | ₫18.8t | ₫2.4t | 12x | 31x | 4x |
| Thu, 19 Jan 2023 | ₫74.6t | ₫17.7t | ₫2.2t | 12.7x | 33.5x | 4.2x |
| Sat, 17 Dec 2022 | ₫76.6t | ₫17.7t | ₫2.2t | 12.8x | 34.4x | 4.3x |
| Mon, 14 Nov 2022 | ₫70.6t | ₫17.7t | ₫2.2t | 12.2x | 31.7x | 4x |
| Wed, 12 Oct 2022 | ₫82.9t | ₫17.2t | ₫2.1t | 14.1x | 39.1x | 4.8x |
| Fri, 09 Sep 2022 | ₫86.7t | ₫17.2t | ₫2.1t | 14.5x | 41.3x | 5x |
| Sun, 07 Aug 2022 | ₫84.0t | ₫17.2t | ₫2.1t | 14x | 39.7x | 4.9x |
| Tue, 05 Jul 2022 | ₫81.7t | ₫16.9t | ₫2.0t | 15x | 40x | 4.8x |
| Thu, 02 Jun 2022 | ₫93.5t | ₫16.9t | ₫2.0t | 15.6x | 45.8x | 5.5x |
| Sat, 30 Apr 2022 | ₫88.2t | ₫16.7t | ₫2.1t | 16.1x | 42.5x | 5.3x |
| Mon, 28 Mar 2022 | ₫118.4t | ₫19.0t | ₫2.4t | 16.9x | 49.5x | 6.2x |
| Wed, 23 Feb 2022 | ₫115.0t | ₫19.1t | ₫2.4t | 16x | 47.5x | 6x |
| Fri, 21 Jan 2022 | ₫105.0t | ₫18.6t | ₫2.4t | 16.3x | 44.1x | 5.6x |
| Sun, 19 Dec 2021 | ₫128.3t | ₫19.5t | ₫2.4t | 17.1x | 53.6x | 6.6x |
| Tue, 16 Nov 2021 | ₫136.5t | ₫19.4t | ₫2.4t | 17.1x | 57.4x | 7.1x |
| Thu, 14 Oct 2021 | ₫129.5t | ₫19.4t | ₫2.4t | 15.5x | 55.1x | 6.7x |
| Sat, 11 Sep 2021 | ₫165.4t | ₫19.9t | ₫2.3t | 15.4x | 71.2x | 8.3x |
| Mon, 09 Aug 2021 | ₫97.2t | ₫19.9t | ₫2.3t | 14.3x | 41.8x | 4.9x |
| Sun, 02 May 2021 | ₫90.4t | ₫19.4t | ₫2.3t | 15x | 39.8x | 4.6x |
Price to Earnings Ratio
39.8x
Current Industry PE
- Investors are pessimistic on the Vietnamese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 19.1x which is lower than its 3-year average PE of 34.6x.
- The 3-year average PS ratio of 4.3x is higher than the industry's current PS ratio of 2.2x.
Past Earnings Growth
- Both revenue and earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.
Industry Trends
Which industries have driven the changes within the Vietnamese Healthcare sector?
| VN Market | 0.98% | |
| Healthcare | -1.05% | |
| Medical Equipment | 3.13% | |
| Healthcare Services | 1.65% | |
| Healthtech | 0% | |
| Biotech | 0% | |
| Life Sciences | 0% | |
| Pharma | -1.28% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 9.0x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 16.3x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 8.6% over the next 5 years.
- This is better than its past earnings decline of 2.4% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 8.6% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DHT Ha Tay Pharmaceutical JSC | ₫28.90k | 8.2% +₫181.1b | 85.2% | PE28x | |
| DCL Cuu Long Pharmaceutical | ₫27.30k | 5.0% +₫95.0b | 18.7% | PE32.3x | |
| DMC Domesco Medical Import - Export | ₫66.70k | 4.2% +₫93.8b | 55.1% | PE14.1x | |
| DBD Binh Dinh Pharmaceutical and Medical Equipment | ₫53.30k | 0.8% +₫29.9b | 23.7% | PE17.2x | |
| LDP Lamdong Pharmaceutical | ₫23.80k | 3.9% +₫11.4b | 186.7% | PS1.6x |